Not checked for notices yet.

Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells

Wanfeng Gao, Xiaoyun Zhang, Wendong Yang and 12 more

Journal for ImmunoTherapy of Cancer · 2019

doi:10.1186/s40425-019-0676-z

Cited by papers we hold 2

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets · 2022
No notice
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.